156 related articles for article (PubMed ID: 17157856)
1. Role of glycoprotein Ia gene polymorphisms in determining platelet function in myocardial infarction patients undergoing percutaneous coronary intervention on dual antiplatelet treatment.
Giusti B; Gori AM; Marcucci R; Sestini I; Saracini C; Paniccia R; Poli S; Giglioli C; Valente S; Prisco D; Gensini GF; Abbate R
Atherosclerosis; 2008 Jan; 196(1):341-348. PubMed ID: 17157856
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of C807T mutation of glycoprotein Ia gene among young male survivors of myocardial infarction: a relation with coronary angiography results.
Lewandowski K; Swierczyńska A; Kwaśnikowski P; Elikowski W; Rzeźniczak M
Kardiol Pol; 2005 Aug; 63(2):107-13; discussion114. PubMed ID: 16136407
[TBL] [Abstract][Full Text] [Related]
3. The contribution of platelet glycoproteins (GPIa C807T and GPIba C-5T) and cyclooxygenase 2 (COX-2G-765C) polymorphisms to platelet response in patients treated with aspirin.
Al-Azzam SI; Alzoubi KH; Khabour OF; Tawalbeh D; Al-Azzeh O
Gene; 2013 Sep; 526(2):118-21. PubMed ID: 23688555
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein Ia C807T: Polymorphisms and Their Association with Platelet Function in Patients with the Acute Coronary Syndrome.
Zhang Q; Jin Y; Shi D; Gong J; Liu J; Lu Y; Tong M; Wang J; Song Q; Dong J; Chen W; Lv K
Cardiology; 2015; 132(4):213-20. PubMed ID: 26304618
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients.
Giusti B; Gori AM; Marcucci R; Saracini C; Sestini I; Paniccia R; Valente S; Antoniucci D; Abbate R; Gensini GF
Pharmacogenet Genomics; 2007 Dec; 17(12):1057-64. PubMed ID: 18004210
[TBL] [Abstract][Full Text] [Related]
6. Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C
Am J Cardiol; 2005 Oct; 96(8):1095-9. PubMed ID: 16214444
[TBL] [Abstract][Full Text] [Related]
7. Residual platelet reactivity is an independent predictor of myocardial injury in acute myocardial infarction patients on antiaggregant therapy.
Marcucci R; Paniccia R; Antonucci E; Poli S; Gori AM; Valente S; Giglioli C; Lazzeri C; Prisco D; Abbate R; Gensini GF
Thromb Haemost; 2007 Oct; 98(4):844-51. PubMed ID: 17938810
[TBL] [Abstract][Full Text] [Related]
8. 807 C/T Polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatment.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Escaned J; Moreno R; Hernández-Antolin R; Sabaté M; Trabetti E; Pignatti PF; Macaya C
Blood Coagul Fibrinolysis; 2004 Jul; 15(5):427-33. PubMed ID: 15205592
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome.
Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Romero-Barra M; Camoin L; Lambert M; Juhan-Vague I; Bonnet JL; Alessi MC
Thromb Haemost; 2007 Feb; 97(2):212-7. PubMed ID: 17264949
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of platelet glycoprotein Ia and the risk for premature myocardial infarction: effects on the release of sCD40L during the acute phase of premature myocardial infarction.
Antoniades C; Tousoulis D; Vasiliadou C; Stefanadi E; Marinou K; Stefanadis C
J Am Coll Cardiol; 2006 May; 47(10):1959-66. PubMed ID: 16697311
[TBL] [Abstract][Full Text] [Related]
11. Association of the gene polymorphisms of platelet glycoprotein Ia and IIb/IIIa with myocardial infarction and extent of coronary artery disease in the Korean population.
Park S; Park HY; Park C; Ko YG; Im EK; Jo I; Shin C; Lee JB; Shim WH; Cho SY; Jang Y
Yonsei Med J; 2004 Jun; 45(3):428-34. PubMed ID: 15227729
[TBL] [Abstract][Full Text] [Related]
12. High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy.
Leé S; Vargová K; Hizoh I; Horváth Z; Gulácsi-Bárdos P; Sztupinszki Z; Apró A; Kovács A; Préda I; Tóth-Zsámboki E; Kiss RG
Thromb Res; 2014 Feb; 133(2):257-64. PubMed ID: 24359966
[TBL] [Abstract][Full Text] [Related]
13. Platelet and leukocyte ROS production and lipoperoxidation are associated with high platelet reactivity in Non-ST elevation myocardial infarction (NSTEMI) patients on dual antiplatelet treatment.
Becatti M; Fiorillo C; Gori AM; Marcucci R; Paniccia R; Giusti B; Violi F; Pignatelli P; Gensini GF; Abbate R
Atherosclerosis; 2013 Dec; 231(2):392-400. PubMed ID: 24267257
[TBL] [Abstract][Full Text] [Related]
14. Effect of platelet receptor gene polymorphisms on outcomes in ST-elevation myocardial infarction patients after percutaneous coronary intervention.
Zhang JH; Wang J; Tang XF; Yao Y; Zhang Y; Ma YL; Xu B; Gao RL; Song L; Gao Z; Chen J; Wu Y; Yang YJ; Meng XM; Yuan JQ
Platelets; 2016; 27(1):75-9. PubMed ID: 25901734
[TBL] [Abstract][Full Text] [Related]
15. Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
Barbieri L; Pergolini P; Verdoia M; Rolla R; Nardin M; Marino P; Bellomo G; Suryapranata H; De Luca G;
Vascul Pharmacol; 2016 Apr; 79():11-15. PubMed ID: 26518440
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
[TBL] [Abstract][Full Text] [Related]
17. [Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation].
Morel O; Viellard C; Faure A; Jesel L; Ohlmann P; Desprez D; Chauvin M; Roul G; Grunebaum L; Bareiss P
Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):21-9. PubMed ID: 17343035
[TBL] [Abstract][Full Text] [Related]
18. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G
Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422
[TBL] [Abstract][Full Text] [Related]
19. Effects of platelet and inflammatory system activation on outcomes in diabetic patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Kuliczkowski W; Greif M; Gąsior M; Kaczmarski J; Pres D; Poloński L
Kardiol Pol; 2011; 69(6):531-7. PubMed ID: 21678284
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.
Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G;
Cardiovasc Ther; 2016 Aug; 34(4):209-15. PubMed ID: 27086085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
